Literature DB >> 228060

Induction of mouse mammary tumor virus RNA in mammary tumors of BALB/c mice treated with urethane, X-irradiation, and hormones.

R Michalides, L van Deemter, R Nusse, P Hageman.   

Abstract

The involvement of mouse mammary tumor virus (MTV) in the development of mammary tumors of nonviral etiology in BALB/c mice was studied by measuring the levels of MTV RNA, MTV DNA, and MTV proteins in spontaneously arising and hormonally, chemically, and/or physically induced mammary tumors of BALB/c females. The following results were obtained. (i) Spontaneous mammary tumors contained very low levels of MTV RNA; 4 X 10(-6)% of the the cytoplasmic RNA was MTV RNA. No MTV proteins could be demonstrated by using sensitive radioimmunoassays for MTV proteins p27 and gp52. (ii) Mammary tumors induced by treatments with urethane or X-irradiation alone contained higher levels of MTV RNA; these tumors contained 3- and 19-fold more MTV RNA, respectively, compared with spontaneous mammary tumors. (iii) Mammary tumors induced by combined treatment with urethane and X-irradiation expressed high levels of MTV RNA in the mammary tumors; a 1,724-fold increase in MTV RNA content compared with spontaneous mammary tumors was observed. However, very low levels of MTV proteins gp52 and p27 were detected, suggesting some kind of impairment at the translation of the MTV RNA. MTV RNA was also induced by this treatment in mammary glands and spleens, but not in the livers of tumor-bearing animals. (iv) Balb/c females continuously exposed to prolactin contained high levels of MTV RNA and MTV proteins in stimulated mammary glands and in the hormonally induced mammary tumors. These findings suggest that MTV is not responsible for the maintenance and probably also not for the development of all murine mammary cancers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228060      PMCID: PMC353422     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

5.  Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins.

Authors:  G Schochetman; C W Long; S Oroszlan; L Arthur; D L Fine
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

6.  Changes in MuMTV DNA and RNA levels in Balb/c mammary epithelial cells during malignant transformation by exogenous MuTV and by hormones.

Authors:  C M McGrath; E J Marineau; B A Voyles
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

7.  Involvement of mouse mammary tumor virus in spontaneous and hormone-induced mammary tumors in low-mammary-tumor mouse strains.

Authors:  R Michalides; L van Deemter; R Nusse; G Röpcke; L Boot
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

8.  Detection of mouse mammary tumor virus RNA in BALB/c tumor cell lines of nonviral etiologies.

Authors:  J P Dudley; J S Butel; S H Socher; J M Rosen
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

Review 9.  Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.

Authors:  C M McGrath; R F Jones
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

10.  Induction of mammary cancer in mice without the mammary tumor agent by isografts of hypophyses.

Authors:  O MUHLBOCK; L M BOOT
Journal:  Cancer Res       Date:  1959-05       Impact factor: 12.701

View more
  8 in total

1.  Genetic changes in mammalian cells reminiscent of an SOS response.

Authors:  P Herrlich; U Mallick; H Ponta; H J Rahmsdorf
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product.

Authors:  D A Wheeler; J S Butel; D Medina; R D Cardiff; G L Hager
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

3.  Quantitative of murine mammary tumor virus-related RNA in mammary tissues of low- and high-mammary-tumor-incidence mouse strains.

Authors:  S L Marcus; S W Smith; N H Sarkar
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

4.  Proviral unit II of endogenous mouse mammary tumour virus is selectively amplified and expressed in C57B1/10 mammary tumours induced by non-viral carcinogens.

Authors:  J Svec
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

5.  Viral RNA content of bovine leukemia virus-infected cells.

Authors:  G Marbaix; R Kettmann; Y Cleuter; A Burny
Journal:  Mol Biol Rep       Date:  1981-05-22       Impact factor: 2.316

6.  Partial expression of endogenous mouse mammary tumor virus in mammary tumors induced in BALB/c mice by chemical, hormonal, and physical agents.

Authors:  J S Butel; S Dusing-Swartz; S H Socher; D Medina
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

7.  Mammary tumor virus proviral DNA in normal murine tissue and non-virally induced mammary tumors.

Authors:  R Michalides; E Wagenaar; B Groner; N E Hynes
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

8.  Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells.

Authors:  B L Slagle; J S Butel
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.